Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...
The National Institute for Health and Care Excellence (NICE) has recommended wider use of kidney biopsies in suspected renal cell carcinoma (RCC). The draft guidance, now open for consultation, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback